← Back to headlines
Ascendis Pharma Reports Significant Revenue Growth in 2025
Ascendis Pharma announced a near doubling of its revenue to €720 million in 2025, driven by the growth of its core products.
20 Feb, 09:10 — 20 Feb, 09:10
ℹOnly 1 source covers this story
